Evans David Thomas 4
4 · Cardlytics, Inc. · Filed Aug 13, 2020
Insider Transaction Report
Form 4
Cardlytics, Inc.CDLX
Evans David Thomas
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2020-08-11+208→ 208 total→ Common Stock (208 underlying) - Exercise/Conversion
Restricted Stock Units
2020-08-11−208→ 0 total→ Common Stock (208 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2020-08-11−741→ 5,509 totalExercise: $20.00Exp: 2026-08-02→ Common Stock (741 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2020-08-11−700→ 11,019 totalExercise: $30.44Exp: 2027-07-07→ Common Stock (700 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2020-08-11−700→ 7,894 totalExercise: $20.00Exp: 2026-12-06→ Common Stock (700 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2020-08-12−5,509→ 0 totalExercise: $20.00Exp: 2026-08-02→ Common Stock (5,509 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2020-08-12−4,769→ 6,250 totalExercise: $30.44Exp: 2027-07-07→ Common Stock (4,769 underlying) - Exercise/Conversion
Common Stock
2020-08-11+208→ 12,987 total - Exercise/Conversion
Common Stock
2020-08-11$20.00/sh+741$14,820→ 13,728 total - Exercise/Conversion
Common Stock
2020-08-11$30.44/sh+700$21,308→ 14,428 total - Exercise/Conversion
Common Stock
2020-08-11$20.00/sh+700$14,000→ 15,128 total - Sale
Common Stock
2020-08-11$75.55/sh−13,019$983,585→ 2,109 total - Sale
Common Stock
2020-08-11$76.05/sh−401$30,496→ 1,708 total - Exercise/Conversion
Common Stock
2020-08-12$20.00/sh+5,509$110,180→ 7,217 total - Exercise/Conversion
Common Stock
2020-08-12$30.44/sh+4,769$145,168→ 11,986 total - Exercise/Conversion
Common Stock
2020-08-12$20.00/sh+4,769$95,380→ 16,755 total - Sale
Common Stock
2020-08-12$77.14/sh−15,047$1,160,726→ 1,708 total - Sale
Common Stock
2020-08-13$79.62/sh−86$6,847→ 1,622 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2020-08-12−4,769→ 3,125 totalExercise: $20.00Exp: 2026-12-06→ Common Stock (4,769 underlying)
Footnotes (8)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
- [F2]The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
- [F3]The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $76.01 to $76.09, inclusive.
- [F4]The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $76.64 to $77.58, inclusive.
- [F5]Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs granted on August 11, 2020.
- [F6]Fully vested.
- [F7]This option becomes exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.
- [F8]This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on December 6, 2017 (the "Initial Vesting Date"). The options becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.